Similarly, cholecystitis rates were approximately 0.6% with semaglutide compared to 0.2% with placebo
10.1038/s41418-024-01286-6 195 SongX.ZhuS.ChenP.HouW.WenQ.LiuJ.et al (2018)
On testing cadence, note that there is no universal evidence-based schedule: the frequency of laboratory monitoring should be individualized according to the therapy being used, underlying medical conditions, treatment response, and current clinical guidelines
On the differences between hypoallergenic, natural, and organic, check out Is Natural Hypoallergenic
Most users don't experience this issue, but awareness helps catch it early if it occurs
General approach: If on Semaglutide 0.5 mg or less: Start tirzepatide at 2.5 mg If on Semaglutide 1.0 mg: Start tirzepatide at 5 mg If on Semaglutide 1.7-2.4 mg: Start tirzepatide at 5-7.5 mg Some providers start everyone at 2.5 mg regardless of previous dose to minimize side effects